Use of cytokine immunotherapy to block CNS demyelination induced by a recombinant HSV-1 expressing IL-2
about
IL-35 is a novel responsive anti-inflammatory cytokine--a new system of categorizing anti-inflammatory cytokinesA comparative study of experimental mouse models of central nervous system demyelination.Suppression of IL-12p70 formation by IL-2 or following macrophage depletion causes T-cell autoreactivity leading to CNS demyelination in HSV-1-infected mice.IL-27 limits central nervous system viral clearance by promoting IL-10 and enhances demyelination.Increased plasma concentrations of interleukin 35 in patients with coronary artery disease.The possible role of the novel cytokines il-35 and il-37 in inflammatory bowel disease.Contribution of IL-12/IL-35 common subunit p35 to maintaining the testicular immune privilege.High IL-35 pleural expression in patients with tuberculous pleural effusion.Distinct subunit pairing criteria within the heterodimeric IL-12 cytokine family.Role of interleukin-2 and herpes simplex virus 1 in central nervous system demyelination in miceIL-35: a potential therapeutic target for controlling hepatitis B virus infection.Roles of M1 and M2 Macrophages in Herpes Simplex Virus 1 Infectivity.In vivo delivery of interleukin-35 relieves coxsackievirus-B3-induced viral myocarditis by inhibiting Th17 cells.The virtues and vices of harnessing HSV vectors for CNS autoimmunity modulation.
P2860
Q21090933-8153952A-9B15-43CC-8109-615600F67D5FQ33717475-4E680F11-D909-40A7-B463-6A9F57B508D6Q33758029-B4719FC5-986C-4BD7-901F-F58F855D55FDQ33795818-917CBCF0-8C02-4282-BFCA-BAE94746A053Q33904487-29516B0C-1F3E-4EF9-9EED-26DC4D81652EQ34119277-ED45886B-E560-4E03-B942-4E8800B531C6Q35156199-82D89C78-6BFF-4542-AB5C-A7B728BC7627Q35605534-E8101434-ED9F-4926-83DF-B22E41100328Q35926091-BECE23BE-F963-4D93-A051-CEE9286AD8C7Q37254368-868A38D2-7CFA-4DE5-8870-EF53D1AEF003Q38283391-B71C6ACB-1123-44D8-B798-8DE4722F5968Q40207052-2E45CAC6-60C6-4517-A097-CEAE67565D26Q42220993-E35A439B-2D8D-40C8-84F7-2E4969A2D83DQ43749965-0EC87E1C-B220-4360-8BC6-F1912962DA15
P2860
Use of cytokine immunotherapy to block CNS demyelination induced by a recombinant HSV-1 expressing IL-2
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Use of cytokine immunotherapy ...... ombinant HSV-1 expressing IL-2
@ast
Use of cytokine immunotherapy ...... ombinant HSV-1 expressing IL-2
@en
type
label
Use of cytokine immunotherapy ...... ombinant HSV-1 expressing IL-2
@ast
Use of cytokine immunotherapy ...... ombinant HSV-1 expressing IL-2
@en
prefLabel
Use of cytokine immunotherapy ...... ombinant HSV-1 expressing IL-2
@ast
Use of cytokine immunotherapy ...... ombinant HSV-1 expressing IL-2
@en
P2093
P2860
P356
P1433
P1476
Use of cytokine immunotherapy ...... ombinant HSV-1 expressing IL-2
@en
P2093
P2860
P2888
P304
P356
10.1038/GT.2011.32
P577
2011-03-17T00:00:00Z